A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain

Title
A Phase II Open-Label Study of Bermekimab in Patients with Hidradenitis Suppurativa Shows Resolution of Inflammatory Lesions and Pain
Authors
Keywords
-
Journal
JOURNAL OF INVESTIGATIVE DERMATOLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2020-01-29
DOI
10.1016/j.jid.2019.10.024

Ask authors/readers for more resources

Find the ideal target journal for your manuscript

Explore over 38,000 international journals covering a vast array of academic fields.

Search

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now